AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2017
Apr 3, 2017
34395_dirs_2017-04-03_30799669-e7fc-416e-85d9-16b6283c581b.zip
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-03-30
Reporting Person: TERRELL JASON BRADLEY MD (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-30 | Stock Option (Right to Buy) | $5 | A | 50000 | Acquired | 2023-03-30 | Common Stock (50000) | Direct |
Footnotes
F1: A total of 50,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.